Thiery M, Benijts G, Derom R, Martens G, Amy J J, van Kets H, Schryver D E
Z Geburtshilfe Perinatol. 1977 Oct;181(5):345-51.
Labor was successfully induced or stimulated with intravenous Prostaglandin E2 (0.1-2.0 microgram/min) in a group of twenty-nine hypertensive gravidae at 36-41 weeks' gestation. No adverse maternal or perinatal effects of the drug were recorded.
在一组29名妊娠36至41周的高血压孕妇中,通过静脉注射前列腺素E2(0.1 - 2.0微克/分钟)成功引产或诱发宫缩。未记录到该药物对母亲或围产期有任何不良影响。